Skip to main content

Table 3 Participant characteristics: overall, characteristics were generally well balanced across the treatment groups

From: Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO)

  

Randomized to leukodepletion

filter (n = 32)

Randomized to standard

Filter (n = 31)

Overall

(n = 63)

n

%

n

%

n

%

Age (years)

Median (IQR)

73.5

(69.6, 77.9)

72.0

(61.5, 76.9)

72.6

(66.1, 77.7)

Male

 

21/32

66%

18/31

58%

39/63

62%

Black ethnicity

 

2/32

6%

0/31

0%

2/63

3%

BMI

Median (IQR)

27.0

(24.4, 32.3)

29.7

(26.0, 34.6)

27.8

(25.5, 33.3)

EuroSCORE

Median (IQR)

6.0

(5.0, 7.0)

6.0

(3.0, 7.0)

6.0

(4.0, 7.0)

Cleveland CSA-AKI score

Median (IQR)

2.0

(1.0, 3.0)

2.0

(2.0, 3.0)

2.0

(1.0, 3.0)

ECHO/ANGIOGRAM REPORT

 LV function

Good (> 50%)

28/32

88%

26/31

84%

54/63

86%

Moderate (30–50%)

4/32

13%

5/31

16%

9/63

14%

 Extent of coronary disease

None/not investigated

22/32

69%

20/31

64%

42/63

66%

Single

2/32

6%

5/31

16%

7/63

11%

Double

3/32

9%

4/31

13%

7/63

11%

Triple

5/32

16%

2/31

6%

7/63

11%

 > 50% disease in left main stem

 

2/32

6%

2/31

6%

4/63

6%